US Bancorp DE Decreases Stock Holdings in UnitedHealth Group Incorporated $UNH

US Bancorp DE lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the third quarter, Holdings Channel reports. The institutional investor owned 1,025,873 shares of the healthcare conglomerate’s stock after selling 14,771 shares during the quarter. US Bancorp DE’s holdings in UnitedHealth Group were worth $354,238,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the business. Brighton Jones LLC boosted its holdings in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH purchased a new position in shares of UnitedHealth Group in the second quarter worth $340,000. Advisory Alpha LLC grew its holdings in shares of UnitedHealth Group by 20.4% during the second quarter. Advisory Alpha LLC now owns 5,486 shares of the healthcare conglomerate’s stock valued at $1,712,000 after buying an additional 931 shares during the last quarter. Finally, Howard Capital Management Inc. raised its stake in UnitedHealth Group by 6.1% in the 2nd quarter. Howard Capital Management Inc. now owns 7,284 shares of the healthcare conglomerate’s stock worth $2,272,000 after acquiring an additional 418 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. Oppenheimer cut their price objective on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Barclays cut their price objective on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Royal Bank Of Canada cut their price target on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Finally, Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $372.13.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $284.11 on Thursday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. The company’s fifty day moving average price is $313.51 and its 200 day moving average price is $325.44. The stock has a market capitalization of $257.35 billion, a P/E ratio of 21.54, a P/E/G ratio of 1.26 and a beta of 0.41. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.02. The business had revenue of $113.73 billion for the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter last year, the business earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be issued a $2.21 dividend. The ex-dividend date is Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 3.1%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.